Purchase Order 36C24226P0716

<p>The Veterans Integrated Service Network 2 awarded a purchase order to Theracom, L.L.C. for $38,875.02 on May 20, 2026, with completion by May 27, 2026. The order is for TAKHZYRO 150MG/ML injection in 2ML syringe formulation. Performance occurs at Brooks, Kentucky. No set-aside was used. Theracom is a child entity of Cencora, Inc. (Amerisourcebergen) and specializes in supplying specialized pharmaceutical therapies to federal healthcare systems.</p>

Theracom, L.L.C., a Kentucky-based specialty pharmaceutical supplier, has been awarded a firm fixed-price purchase order valued at $38,875.02 by Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs for the supply of TAKHZYRO 150MG/ML injection in 2ML syringe formulation. The contract was awarded on April 15, 2026, with an ultimate completion date of April 21, 2026, and carries no set-aside designation. Performance will be executed at Theracom's location in Brooks,...

The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a firm fixed-price purchase order to Theracom, L.L.C. on April 27, 2026, for the supply of TAKHZYRO 150 MG, a specialized biologic pharmaceutical therapy. The contract carries a ceiling value of $38,097.52 with an ultimate completion date of April 30, 2026, and was awarded without set-aside designation on a full and open competitive basis. Theracom, a Kentucky-based pharmaceutical supply company...

<p>The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a purchase order to Theracom, L.L.C. for TAKHZYRO 150 MG with a ceiling value of $38,097.52 on May 19, 2026, with completion by May 20, 2026. No set-aside was used. Performance occurs at Brooks, Kentucky. The order is firm fixed-price for the supply of this specialized pharmaceutical therapy to the federal healthcare system.</p>

The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a firm fixed-price purchase order to Theracom, L.L.C. for $38,097.52 for the supply of TAKHZYRO 150 MG, a specialized biologic pharmaceutical therapy. The contract was awarded on March 2, 2026, with an ultimate completion date of March 4, 2026, and no set-aside designation was utilized. Theracom, headquartered in Shepherdsville, Kentucky and operating from its Brooks, Kentucky facility, is a specialized...

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for TAKHZYRO 300 mg/2 ml syringe with a ceiling value of $37,281.14. The order is placed under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 running through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is March 30, 2026. Pricing is firm fixed price, and no set-aside was used.

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 6, 2026, for TAKHZYRO 300 mg/2 ml syringes with a ceiling value of $18,640.57.</p> <p>Place of performance is Conshohocken, PA 19428. The order is due March 2, 2026. The delivery order is priced on a firm fixed-price basis and is issued without a set-aside.</p>

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for Takhzyro 300 mg/2 mL syringes with a ceiling value of $18,640.57. Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of March 17, 2026. This delivery order was issued under the company's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supplies...

On January 15, 2026, the Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a delivery order valued at $38,097.52 to Takeda Pharmaceuticals America Inc. for TAKHZYRO 150 MG, a specialized pharmaceutical product used to treat rare genetic disorders. This firm fixed-price delivery order, with an ultimate completion date of January 20, 2026, represents a child contract under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and does not utilize a set-aside...

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for Takhzyro 300 mg/2 ml syringe, 2 ml, with a ceiling value of $18,640.57.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 4, 2026. No set-aside was used.</p>